quant Healthcare Fund · Regular · Growth
NAV
₹17.4426
as of 31 Jul 2026
Expense Ratio
2.42%
AUM
₹361 Cr
Lumpsum returns (CAGR)
- 1Y
- +13.71%
- 3Y
- +19.40%
- 5Y
- —
- Since Inception
- +20.09%
SIP returns (XIRR)
- 1Y
- +25.74%
- 3Y
- +14.55%
- 5Y
- —
- Since Inception
- +14.55%
What history actually did — last 3 years (Aug 2023 – Jul 2026)
A ₹5,000 monthly SIP for the last 3 years (Aug 2023 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹2,11,791 today — ₹1,75,000 invested, 13.3% XIRR.
₹1,75,000
Invested
₹2,11,791
Value today
13.3%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 3 years (Aug 2023 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 3 years ago would be ₹1,68,700 today (19.1% CAGR).
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹2,11,791 in this fund vs ₹1,93,253 in the benchmark — outperformance of ₹18,538.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 3 years (Aug 2023 – Jul 2026) (3 Jun 2024) would be ₹1,24,003 today (1.24×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.25
Sharpe Ratio
+0.07
Alpha
0.32
Beta
0.25
Sortino
17.39%
Std Dev
-14.33%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology49.00%
- Food Products9.00%
- Healthcare Services9.00%
- Insurance8.00%
- Telecom - Services7.00%
- Retailing4.00%
Each sector links to the mutual funds most exposed to it.
Thinking about quant Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Zydus Wellness Ltd9.27%
- 2Anthem Biosciences Limited9.17%
- 3Aster Dm Healthcare Limited8.90%
- 4Sms Pharmaceuticals Limited8.86%
- 5Sequent Scientific Limited8.62%
- 6Alivus Life Sciences7.27%
- 7Hfcl Limited7.14%
- 8Pfizer Ltd6.42%
- 9Aurobindo Pharma Limited5.15%
- 10Icici Prudential Life Insurance Co Ltd4.35%
Investment Objective
quant Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
quant Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by quant Mutual Fund. The fund has been operational for over 3 years. It manages assets worth ₹361 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY HEALTHCARE INDEX TRI. The current expense ratio is 2.42%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations